Hereditary spastic paraplegia (HSP) is a diverse group of inherited di
sorders characterized by progressive lower-extremity spasticity and we
akness. Insight into the genetic basis of these disorders is expanding
rapidly. Uncomplicated autosomal dominant, autosomal recessive, and X
-linked HSP are genetically heterogeneous: different genes cause clini
cally indistinguishable disorders. A locus for autosomal recessive HSP
is on chromosome 8q. Loci for autosomal dominant HSP have been identi
fied on chromosomes 2p, 14q, and 15q. One locus (Xq22) has been identi
fied for X-linked, uncomplicated HSP and shown to be due to a proteoli
poprotein gene mutation in one family. The existence of HSP families f
or whom these loci are excluded indicates the existence of additional,
as yet unidentified HSP loci. There is marked clinical similarity amo
ng HSP families linked to each of these loci, suggesting that gene pro
ducts from HSP loci may participate in a common biochemical cascade, w
hich, if disturbed, results in axonal degeneration that is maximal at
the ends of the longest CNS axons. Identifying the single gene defects
that cause HSPs distal axonopathy may provide insight into factors re
sponsible for development and maintenance of axonal integrity. We revi
ew clinical, genetic, and pathologic features of HSP and present diffe
rential diagnosis and diagnostic criteria of this important group of d
isorders. We discuss polymorphic microsatellite markers useful for gen
etic linkage analysis and genetic counseling in HSP.